3
ISSUE
PIE M A G A ZINE’ S D A ILY CONGR E S S NE W S ON T HE P O S T E RIOR S EGME N T
posterior segment
•
innovation
•
09 | 21 | 24
enlightenment
HIGHLIGHTS 04
APVRS announced consensus statements on PCV.
06
First impressions on aflibercept 8 mg PFS... find out more.
Published by
Matt Young CEO & Publisher
Gloria D. Gamat Chief Editor
Matt Herman Associate Editor
Kreissig Lecture
A Legacy of Retinal Detachment Research
Maricel Salvador
by Tan Sher Lynn
Graphic Designer Writers
Diana Truong Tan Sher Lynn
Hannah Nguyen COO
Travis Plage CFO
Ruchi Ranga Society Relations & Conference Manager International Business Development
Brandon Winkeler Robert Anderson Sven Mehlitz
The 2024 Kreissig Award Lecture, delivered by recipient Prof. Taiji Sakamoto from Japan on Day 3 of the 24th Congress of the European Society of Retina Specialists (EURETINA 2024) was a moving tribute to both innovation in retinal surgery and the profound mentorship of Professor Ingrid Kreissig, one of the pioneering figures in retinal detachment treatment.
T
his year’s Kreissig Award Lecture not only highlighted Prof. Sakamoto’s extensive contributions to the field of ophthalmology but also underscored the enduring legacy of Prof. Kreissig, a pioneering figure in retinal detachment treatment who became the first woman to serve as a surgical chair in ophthalmology at the University of Tübingen (Germany) in 1979. A role model for many, especially women in medicine, Prof. Kreissig’s influence has been profound, both in Europe and worldwide.
Media MICE Pte. Ltd.
6001 Beach Road, #09-09 Golden Mile Tower, Singapore 199589 Tel: +65 8186 7677 Email: enquiry@mediamice.com www.mediaMICE.com
In his speech, Prof. Sakamoto honored her leadership, recalling how she mentored
him while he prepared for the lecture. “Sometimes her guidance was strict, but there was always warmth and kindness in her comments. It was a privilege to receive her direct feedback,” he recalled. Then, Prof. Sakamoto, who is currently the Vice President of Kagoshima University in Japan and the President of the Japan Retinal Virtual Society, took the audience on a journey through his 30-year career in ophthalmology, which he divided into three key phases: his work in basic science, his clinical practice, and his current role as a leader in academic society.
Cont. on Page 3 >>